CJC/IPA Blend combines a GHRH analog such as CJC-1295 with Ipamorelin, a ghrelin-receptor agonist. The blend is meant to bring together two different upstream pathways involved in endogenous growth-hormone signaling. It is described as a research blend used in endocrine signaling studies.
Top Selling CJC/IPA Blend Compounds Products
Frequently Asked Questions
Explore answers to our most commonly asked questions about CBD, our products, and more.
This blend is usually studied for pulsatile growth-hormone release, GH/IGF-1 signaling, and experimental models of endocrine signaling. The exact behavior of the blend depends on whether the CJC component is DAC or non-DAC, since that changes its half-life and pulse pattern.